Sandoz Glimepiride (2014-01-24) Jan 27, 2014 · Published by Health Canada · Official notice
Share
Alert type : Drug Recall
Category : Drugs
Issue : Product Safety
Audience : General Public, Healthcare Professionals, Hospitals
Department : Health Canada
Hazard classification : Type I
Lot or serial number Companies Brand name Dosage form DIN, NPN, DIN-HIM Strength DM5336 Recalling Firm Sandoz Canada Inc. 145 Jules-Léger Boucherville J4B 7K8 Quebec CANADA Marketing Authorization Holder Sandoz Canada Inc. 145 Jules-Léger Boucherville J4B 7K8 Quebec CANADA B. Sandoz Glimepiride, 2 mg Tablet DIN 02269597 2 mg DM5336 Recalling Firm Sandoz Canada Inc. 145 Jules-Léger Boucherville J4B 7K8 Quebec CANADA Marketing Authorization Holder Sandoz Canada Inc. 145 Jules-Léger Boucherville J4B 7K8 Quebec CANADA A. Sandoz Glimepiride, 1 mg Tablet DIN 02269589 1 mg
Recalled products
A. Sandoz Glimepiride, 1 milligram (mg)
B. Sandoz Glimepiride, 2 mg
Recall initiated following the discovery of blisters of Sandoz Glimepiride 2 mg tablets, Lot DM5336, erroneously packaged in a box identified Sandoz Glimepiride 1 mg. Therefore, units of this lot could be found in 1 mg or 2 mg inventories.
Wholesalers and pharmacies in Canada